Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Indian shares rise one per cent lifted by pharma
Indian shares ended up one per cent yesterday in broad-based buying, led by a surge in pharma stocks, even as global markets…
SC notice to Centre on plea alleging shortage of anti-HIV drugs
Antiretroviral Therapy (ART) is treatment of people infected with Human Immunodeficiency Virus (HIV) using anti-HIV drugs
Zydus launches Lenalidomide capsules
Lenalidomide is used to treat various types of cancers
Haleon rejects Zantac indemnification requests from GSK and Pfizer
Zantac, originally marketed by a forerunner of GSK, has been sold by several companies at different times, including Pfizer,…
Alkem, in partnership with Stempeutics, launches stem cell therapy to treat knee osteoarthritis
The treatment comprises a single intra-articular injection of “StemOne” in an outpatient procedure with no anaesthesia requirement
Indoco’s AnaCipher CRO clears US FDA inspection with Zero 483s
The CRO, located in Hyderabad, was inspected by the FDA from 12th to 16th September, 2022
Bugworks Research and Cytecare Cancer Hospitals partner to accelerate development of immuno-oncology…
Bugworks' drug discovery engine coupled with Cytecare's clinical outcomes will offer differentiated solutions to patients all over…
European Commission approves Roche’s Vabysmo to treat vision loss
Vabysmo is the only injectable eye medicine approved in Europe with phase-III studies supporting treatment at intervals of up to…
Sandoz announces positive results for biosimilar Denosumab
The results came soon after Sandoz confirmed acceptance of licence applications for two other proposed biosimilars
EU recommends marketing approval for Evusheld to treat COVID-19
Recommendation based on Tackle phase-III treatment data showing reduced risk of severe COVID-19 or death